Summary and conclusions
Biological systems operate at the nanoscale. Nanomedicine is the application of nanotechnology to monitor and treat biological systems in health and disease. This is accomplished by real time monitoring of molecular signaling at the cellular and tissue level. During the past decade, there has been an explosion in this field, resulting in revolutionary advances in determining the microstructure and function of living systems. These discoveries have led to the development of powerful tools for fundamental biological and medical research. Nanotechnology has been applied to targeted drug delivery to minimize side effects, creating implantable materials as scaffolds for tissue engineering, creating implantable devices, surgical aids and nanorobotics, as well as throughput drug screening and medical diagnostic imaging. The nanoinitiatives are funded by governments and private sources throughout the world to develop or further refine the technology to provide the beyond-imaginable, most sophisticated tools to a physician and scientists to inflammatory diseases. No doubt, there will be many technical, regulatory and legal challenges in the deployment of these technologies. Unquestionably, there is enough desire and commitment to meet these challenges for the good of society and betterment of the quality of life.
Chapter PDF
Similar content being viewed by others
Keywords
- Carbon Nanotubes
- Fluorescence Resonance Energy Transfer
- Iron Oxide Nanoparticles
- Liposomal Formulation
- Fluorescence Lifetime Imaging Microscopy
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
References
Fiocchi C (1997) Intestinal inflammation: a complex interplay of immune and nonimmune cell interactions. Am J Physiol 273: G769–G775
National Nanotechnology Initiative: www.nano.gov
Brannon-Pepppas L, Blanchette JO (2004) Nanoparticle and targeted systems for cancer therapy. Adv Drug Deliv Rev 56(11): 1649–1659
Wheatley MA, Forsberg F, Dube N, Patel M, Oeffinger BE (2006) Surfactant stabilized contrast agent on the nanoscale for diagnostic ultrasound imaging. Ultrasound Med Biol 32(1): 83–93
Choi NS, Yoo KH, Yoon KS, Maeng PJ, Kim SH (2004) Nano-scale proteomics approach using two-dimensional fibrin zymography combined with fluorescent SYPRO ruby dye. J Biochem Mol Biol 37(3): 298–303
Vo-Dinh T, Yan F, Stokes DL (2005) Plasmonics-based nanostructures for surfaceenhanced Raman scattering bioanalysis. Methods Mol Biol 300: 255–283
West JL, Halas NJ (2003) Engineered materials for biophotonics applications: improving sensing, and therapeutics. Annu Rev Biomed Eng 5: 285–292
Hernando A, Crespo P, Garcia MA (2005) Metallic magnetic nanoparticles. Scientific World Journal 5: 972–1001
Cloninger MJ (2002) Biological applications of dendrimers. Curr Opin Chem Biol 6(6): 742–748
Moghimi SM, Hunter CA, Murray JC (2005) Nanomedicine: current status and future prospects”. FASEB J 19: 311–330
Zhang S (2002) Emerging biological materials through molecular self-assembly. Biotechnol Adv 20: 321–339
Sparks D, Hubbard T (2004) Micromachined needles and lancets with design adjustable bevel angles. J Micromech Microeng 14: 1230–1233
McAllister DV, Allen MG, Prausnitz MR (2000) Microfabricated microneedles for gene and drug delivery. Ann Rev Biomed Eng 2: 289–313
Jain KK (2005) Role of nanobiotechnology in developing personalized medicine for cancer. Technol Cancer Res Treat 4(6): 645–650
Hayes ME, Drummond DC, Kirpotin DB, Zheng WW, Noble CO, Park JW, Marks JD, Benz CC, Hong K (2006) Genospheres: self-assembling nucleic acid-lipid nanoparticles suitable for targeted gene delivery. Gene Therapy 13(7): 646–651
Wenonah Vercoutere W, Winters-Hilt S, Olsen H, Deamer D, Haussler D, Akeson M (2001) Rapid discrimination among individual DNA hairpin molecules at singlenucleotide resolution using an ion channel. Nat Biotechnol 19: 248–252
Zhang S (2001) Molecular self-assembly. In: Encyclopedia of Materials: Science & Technology. Elsevier Science, Oxford, 5822–5829
Majumdar A (2002) Bioassays based on molecular nanomechanics. Dis Markers 18: 167–174
Kam NW, Liu Z, Dai H, (2006) Carbon nanotubes as intracellular transporters for proteins and DNA: an investigation of the uptake mechanism and pathway. Angew Chem Int Ed Engl 45(4): 577–581
Kam NW, Dai H, (2005), Carbon nanotubes as intracellular protein transporters: generality and biological functionality. J Am Chem Soc 127(16): 6021–6026
Zhu HW, Xu CL, Wu DH, Wei BQ, Vajtai R, Ajayan PM, (2002) Direct synthesis of long single-walled carbon nanotubes strands. Science 296: 884
Raviv U, Needleman DJ, Li Y, Miller HP, Wilson L, Safinya CR (2005) Cationic liposome-microtubule complexes: Pathways to the formation of two-state lipid-protein nanotubes with open or closed ends. Proc Natl Acad Sci USA 102: 11167–11172
Kooi ME, Cappendijk VC, Cleutjens KB, Kessels AG, Kitslaar PJ, Borgers M (2003) Accumulation of ultra-small super paramagnetic particles of iron oxide in human atherosclerotic plaques can be detected by in vivo magnetic resonance imaging. Circulation 107: 2453–2458
West JL, Halas NL (2000) Applications of nanotechnology to biotechnology. Curr Opin Biotech 11: 215–217
Han M, Gao X, Su JZ, Nie S (2001) Quantum-dot-tagged microbeads for multiplexed optical coding of biomolecules. Nat Biotechnol 19: 631–635
Medintz IL, Uyeda HT, Goldman ER, Mattoussi H (2005) Quantum dot bioconjugates for imaging, labeling and sensing. Nat Mater 4: 435–446
Lovric J, Bazzi HS, Cuie Y, Fortin GR, Winnik FM, Maysinger D (2005) Differences in subcellular distribution and toxicity of green and red emitting CdTe quantum dots. J Mol Med 83(5): 377–385
Anzai Y (2004) Superparamagnetic iron oxide nanoparticles: nodal metastases and beyond. Top Magn Reson Imaging 15(2): 103–111
Lewin M, Carlesso N, Tung CH, Tang XW, Cory D, Scadden DT (2000) Tat peptidederivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat Biotechnol 18: 410–414
Yang H, Kao WJ (2006) Dendrimers for pharmaceutical and biomedical applications. J Biomater Sci Polym Ed 17: 3–19
Lee CC, McKay JA, Frechet JM, Szoka FC (2005) Designing dendrimers for biological applications. Nat Biotechnol 12: 1517–1526
Yan GP, Hu B, Liu ML, Li LY (2005) Synthesis and evaluation of gadolinium complexes based on PAMAM as MRI contrast agents. J Pharm Pharmacol 57(3): 351–357
Meng F, Engbers GH, Feijen J (2005) Biodegradable polymersomes as a basis for artificial cells: encapsulation, release and targeting. J Control Release 101: 187–198
Ghoroghchian PP, Frail RP, Susumu K, Blessington D, Brannan AK, Bates FS, Chance B, Hammer DA, Therien MJ (2005) Near-infrared-emissive polymersomes: self-assembled soft matter for in vivo optical imaging. Proc Natl Acad Sci USA 102(8): 2922–2927
Torchilin VP(2005) Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov 4(2): 145–160
Reiner JE, Wells JM, Kishore RB, Pfefferkom C, Helmerson K (2006) Stable and robust polymer nanotubes stretched from polymersomes. Proc Natl Acad Sci USA 103(5): 1173–1177
Kubik T, Bogunia-Kubik K, Sugisaka M (2005) Nanotechnology on duty in medical applications. Curr Pharm Biotechnol 6: 17–33
Patolsky F, Zheng G, Hayden O, Lakadamyali M, Zhuang X, Lieber C (2004) Electrical detection of single viruses. Proc Natl Acad Sci USA 101: 14017–14022
Hirsch LR, Halas NJ, West JL (2005) Whole-blood immunoassay facilitated by gold nanoshell-conjugate antibodies. Methods Mol Biol 303: 101–111
Shao Z, Zhang Y (1996) Biological cryo atomic force microscopy: a brief review. Ultramicroscopy 66(3–4): 141–152
Florin EL, Moy VT, Gaub HE (1994) Adhesion forces between individual ligand-receptor pairs. Science 264(5157): 415–417
Kuznetsov YG, Victoria JG, Low A, Robinson WE, Fan H, McPherson A (2004) Atomic force microscopy imaging of retroviruses: human immunodeficiency virus and murine leukemia virus. Scanning 26(5): 209–216
Sheng X, Jung T, Wesson JA, Ward MD (2005) Adhesion at calcium oxalate crystal surfaces and the effect of urinary constituents. Proc Natl Acad Sci USA 102(2): 267–272
Lynch M, Mosher C, Huff J, Nettikadan S, Johnson J, Henderson E (2004) Functional protein nanoarrays for biomarker profiling. Proteomics 4: 1695–1702
Lee KB, Park SJ, Mirkin CA, Smith JC, Mirkisch M (2002) Protein nanoarrays generated by Dip-Pen nanolithography. Science 295: 1703–1705
Barauskas J, Johnson M, Tiberg E (2005) Self-assembled lipid superstructures: beyond vesicles and liposomes. Nano Lett 5(8): 1615–1619
Cattel L, Ceruti M, Dosio F (2004) From conventional to stealth liposomes: a new frontier in cancer chemotherapy. J Chemother 16(Suppl 4): 94–97
Matsumura Y, Gotoh M, Muro K, Yamada Y, Shirao K, Shimada Y, Okuwa M, Matsumoto S, Miyata Y, Ohkura H et al (2004) Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX/Doxil) versus conventional doxorubicin for first-line treatment of metastatic breast cancer. Ann Oncol 15(3): 440–449
Lipshultz SE, Rifai N, Dalton VM, Levy DE, Silverman LB, Lipsitz SR, Colan SD, Asselin BL, Barr RD, Clavell LA et al (2004) The effect of dexrazoxane on myocardial injury in doxorubicin-treated children with acute lymphoblastic leukemia. N Engl J Med 351(2): 145–153
Working PK, Newman MS, Sullivan T, Brunner M, Podell M, Sahenk Z, Turner N (1998) Comparative intravenous toxicity of cisplatin solution and cisplatin encapsulated in long-circulating, pegylated liposomes in cynomolgus monkeys. Toxicol Sci 46(1): 155–165
Harrington KJ, Lewanski CR, Northcote AD, Whittaker J, Wellbank H, Vile RG, Peters AM, Stewart JS (2001) Phase I-II study of pegylated liposomal cisplatin (SPI-077) in patients with inoperable head and neck cancer. Ann Oncol 12(4): 493–496
Meerum Terwogt JM, Groenewegen G, Pluim D, Maliepaard M, Tibben MM, Huisman A, ten Bokkel Huinink WW, Schot M, Welbank H, Voest EE et al (2002) Phase I and pharmacokinetic study of SPI-77, a liposomal encapsulated dosage form of cisplatin. Cancer Chemother Pharmacol 49(3): 201–210
Stathopoulos GP, Boulikas T, Vougiouka M, Deliconstantinos G, Rigatos S, Darli E, Viliotou V, Stathopoulos JG (2005) Pharmacokinetics and adverse reactions of a new liposomal cisplatin (Lipoplatin): phase I study. Oncol Rep 13(4): 589–595
Mastrobattista E, Koning GA, Storm G (1999) Immunoliposomes for the targeted delivery of antitumor drugs. Adv Drug Deliv Rev 40(1–2): 103–127
Park JW, Hong K, Kirpotin DB, Colbern G, Shalaby R, Baselga J, Shao Y, Nielsen UB, Marks JD, Moore D, Papahadjopoulos D, Benz CC (2002) Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery. Clin Cancer Res 8(4): 1172–1181
Mamot C, Drummond DC, Greiser U, Hong K, Kirpotin DB, Marks JD, Park JW (2003) Epidermal growth factor receptor (EGFR)-targeted immunoliposomes mediate specific and efficient drug delivery to EGFR-and EGFRvIII-overexpressing tumor cells. Cancer Res 63(12): 3154–3161
Kesisoglou F, Zhou SY, Niemiec S, Lee JW, Zimmermann EM, Fleisher D (2005) Liposomal formulations of inflammatory bowel disease drugs: local versus systemic drug delivery in a rat model. Pharm Res 22(8): 1320–1330
Metselaar JM, van den Berg WB, Holthuysen AE, Wauben MH, Storm G, van Lent PL (2004) Liposomal targeting of glucocorticoids to synovial lining cells strongly increases therapeutic benefit in collagen type II arthritis. Ann Rheum Dis 63(4): 348–353
Konduri KS, Nandedkar S, Duzgunes N, Suzara V, Artwohl J, Bunte R, Gangadharam PR (2003) Efficacy of liposomal budesonide in experimental asthma. J Allergy Clin Immunol 111(2): 321–327
Christofidou-Solomidou M, Muzykantov VR (2006) Antioxidant strategies in respiratory medicine. Treat Respir Med 5(1): 47–78
Jain S, Jain N, Bhadra D, Tiwary AK, Jain NK (2005) Transdermal delivery of an analgesic agent using elastic liposomes: preparation, characterization and performance evaluation. Curr Drug Deliv 2(3): 223–233
Huang W, Bai Y, Wang JD, Wu JB, Li GF, Zhang WM, Zhou DY (2005) Preparation oral liposome-encapsulated recombinant Helicobacter pylori heat shock protein 60 vaccine for prevention of Hp infection. Di Yi Jun Yi Da Xue Xue Bao 25(5): 531–534
Seth AK, Misra A, Umrigar D (2004) Topical liposomal gel of idoxuridine for the treatment of herpes simplex: pharmaceutical and clinical implications. Pharm Dev Technol 9(3): 277–289
Pantarotto D, Partidos CD, Hoebeke J, Brown F, Kramer E, Briand JP, Muller S, Prato M, Bianco A (2003) Immunization with peptide-functionalized carbon nanotubes enhances virus-specific neutralizing antibody responses. Chem Biol 10(10): 961–966
Dugan LL, Lovett EG, Quick KL, Lotharius J, Lin TT, O’Malley KL (2001) Fullerenebased antioxidants and neurodegenerative disorders. Parkinsonism Relat Disord 7(3): 243–246
Bianco A (2004) Carbon nanotubes for the delivery of therapeutic molecules. Expert Opin Drug Deliv 1(1): 57–65
Quintana A, Raczka, Piehler L, Lee I, Myc A, Majoros I, Patri AK, Thomas T, Mule J, Baker JR (2002) Design and function of a dendrimer-based therapeutic nanodevice targeted to tumor cells through the folate receptor. Pharm Res 19(9): 1310–1316
Ibrahim NK, Desai N, Legha S, Soon-Shiong P, Theriault RL, Rivera E, Esmaeli B, Ring SE, Bedikian A, Hortobagyi GN, Ellerhorst JA (2002) Phase I and pharmacokinetic study of ABI-007, a Cremophor-free, protein-stabilized, nanoparticle formulation of paclitaxel. Clin Cancer Res 8(5): 1038–1044
Kriz K, Ibraimi F, Lu M, F, Lars-Olof Hansson L-O, Kriz D (2005) Detection of C-reactive protein utilizing magnetic permeability detection based immunoassays. Anal Chem 77: 5920–5924
Ackerman ME, Chan W, Laakkonen P, Bhatia SN, Rhoshahti (2002) Nanocrystal imaging in vivo. Proc Natl Acad Sci USA 99: 12167–12621
Gao X, Cui Y, Levenson RM, Chung LW, Nie S (2004) In vivo cancer targeting and imaging with semiconductor quantum dots. Biotechnology 22: 969–976
Mitchell P (2001) Turning the spotlight on cellular imaging. Nat Biotechnol 19(11): 1013–1017
Voura EB, Jaiswal JK, Mattoussi H, Simon SM (2004) Tracking metastatic tumor cell extravasation with quantum dot nanocrystals and fluorescence emission-scanning microscopy. Nat Med 10(9): 993–998
Michalet X, Pinaud FF, Bentolila LA, Tsay JM, Doose S, Li JJ, Sundaresan G, Wu AM, Gambhir SS, Weiss S (2005) Quantum dots for live cells, in vivo imaging, and diagnostics. Science 307(5709): 538–544
Soltesz EG, Kim S, Kim SW, Laurence RG, De Grand AM, Parungo CP, Cohn LH, Bawendi MG, Frangioni JV (2006) Sentinel lymph node mapping of the gastrointestinal tract by using invisible light. Ann Surg Oncol 13(3): 386–396
Jaiswal JK, Simon SM (2004) Potentials and pitfalls of fluorescent quantum dots for biological imaging. Trends Cell Biol 14(9): 497–504
Perez JM, Josephson L, Weissleder R (2004) Use of magnetic nanoparticles as nanosensors to probe for molecular interactions. Chembiochem 5(3): 261–264
Harisinghani MG, Barentsz J, Hahn PF, Deserno WM, Tabatabaei S, van de Kaa CH, de la Rosette J, Weissleder R (2003) Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med 348(25): 2491–2499
Bogdanov A Jr, Matuszewski L, Bremer C, Petrovsky A, Weissleder R (2002) Oligomerization of paramagnetic substrates result in signal amplification and can be used for MR imaging of molecular targets. Mol Imaging 1(1): 16–23
Grimm J, Perez JM, Josephson L, Weissleder R (2004) Novel nanosensors for rapid analysis of telomerase activity. Cancer Res 64(2): 639–643
West, JL (2003) Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance. Proc Natl Acad Sci USA 100: 13549–13554
Shikata F, Tokumitsu H, Ichikawa H, Fukumori Y (2002) In vitro cellular accumulation of gadolinium incorporated into chitosan nanoparticles designed for neutron-capture therapy of cancer. Eur J Pharm Biopharm 53(1): 57–63
Saito R, Krauze MT, Bringas JR, Noble C, McKnight TR, Jackson P, Wendland MF, Mamot C, Drummond DC, Kirpotin DB et al (2005) Gadolinium-loaded liposomes allow for real-time magnetic resonance imaging of convection-enhanced delivery in the primate brain. Exp Neurol 196: 381–389
Chatziioannou AF (2002) PET scanners dedicated to molecular imaging of small animal models. Mol Imaging Biol 4: 47–63
Cherry SR (2004) In vivo molecular and genomic imaging: new challenges for imaging physics. Phys Med Biol 49: R13–R48
Choy G, Choyke P, Libutti SK (2003) Current advances in molecular imaging: noninvasive in vivo bioluminescent and fluorescent optical imaging in cancer research. Mol Imaging 2: 303–312
Tsourkas A, Shinde-Patil VR, Kelly KA, Patel P, Wolley A, Allport JR, Weissleder R (2005) In vivo imaging of activated endothelium using an anti-vcam-1 magnetooptical probe. Bioconjugate Chem 16: 576–581
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Birkhäuser Verlag Basel/Switzerland
About this chapter
Cite this chapter
Murthy, S., Papazoglou, E., Kanagarajan, N., Murthy, N.S. (2006). Nanotechnology: Towards the detection and treatment of inflammatory diseases. In: Stevenson, C.S., Marshall, L.A., Morgan, D.W. (eds) In Vivo Models of Inflammation. Progress in Inflammation Research. Birkhäuser Basel. https://doi.org/10.1007/978-3-7643-7520-1_8
Download citation
DOI: https://doi.org/10.1007/978-3-7643-7520-1_8
Publisher Name: Birkhäuser Basel
Print ISBN: 978-3-7643-7519-5
Online ISBN: 978-3-7643-7520-1
eBook Packages: MedicineMedicine (R0)